ICICI Securities Ltd | Retail Equity Research Revenues grew 15% YoY to | 1662 crore (I-direct estimate: | 1672 crore) on the back of 10% growth in the healthcare business to | 918 crore (I-direct estimate: | 913 crore) and 22% increase in pharmacy business to | 743 crore (I-direct estimate: | 759 crore) EBITDA margins declined 235 bps YoY to 10.2% (I-direct estimate: 13.2%) mainly due to higher other expenditure. EBITDA declined 6% YoY to | 170 crore (I-direct estimate: | 220 crore)...